[HTML][HTML] Diagnostic and prognostic values of KRAS mutations on EUS-FNA specimens and circulating tumor DNA in patients with pancreatic cancer
R Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - Clinical and …, 2022 - journals.lww.com
METHODS: The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer
R Wang, Z Yuchong, Y Wang… - Clinical and …, 2022 - search.proquest.com
METHODS: The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
[HTML][HTML] Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer
R Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - Clinical and …, 2022 - ncbi.nlm.nih.gov
METHODS: The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
[HTML][HTML] Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer
R Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - Clinical and …, 2022 - journals.lww.com
METHODS: The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer
R Wang, Y Zhao, Y Wang, Z Zhao… - Clinical and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The ability of carbohydrate antigen 19-9 (CA19-9) to differentiate pancreatic
cancer from other benign pancreatic lesions is unsatisfactory. This study explored the …
cancer from other benign pancreatic lesions is unsatisfactory. This study explored the …
Diagnostic and prognostic values of KRAS mutations on EUS-FNA specimens and circulating tumor DNA in patients with pancreatic cancer
R Wang, J Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - 2020 - researchsquare.com
Background: Early diagnosis is critical in reducing pancreatic cancer mortality. We explore
the diagnostic values of detecting KRAS gene mutations and plasma circulating tumor DNA …
the diagnostic values of detecting KRAS gene mutations and plasma circulating tumor DNA …
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer.
R Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - Clinical and …, 2022 - europepmc.org
Methods The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer.
R Wang, Y Zhao, Y Wang, Z Zhao… - Clinical & …, 2022 - search.ebscohost.com
INTRODUCTION: The ability of carbohydrate antigen 19-9 (CA19-9) to differentiate
pancreatic cancer from other benign pancreatic lesions is unsatisfactory. This study explored …
pancreatic cancer from other benign pancreatic lesions is unsatisfactory. This study explored …
Diagnostic and prognostic values of KRAS mutations on EUS-FNA specimens and circulating tumor DNA in patients with pancreatic cancer
R Wang, J Wang, Y Zhao, Y Wang, Z Zhao, Q Chen… - 2020 - europepmc.org
Background: Early diagnosis is critical in reducing pancreatic cancer mortality. We explore
the diagnostic values of detecting KRAS gene mutations and plasma circulating tumor DNA …
the diagnostic values of detecting KRAS gene mutations and plasma circulating tumor DNA …